CD276 and thyroid cancer: To confirm the hypothesis that B7-H3 may represent a valuable target antigen for CAR T cell-based immunotherapy, we first evaluated its expression profile across thyroid cancers by utilizing the previously mentioned publicly available database (GSE126698).